|
|
Prepublished online as a Blood First Edition Paper on August 1, 2002; DOI 10.1182/blood-2001-12-0365.
Submitted January 3, 2002
Accepted July 6, 2002
Development of sensitive fluorescent assays for embryonic and fetal hemoglobin inducers using the human ß-globin locus in erythropoietic cells
Jim Vadolas, Hady Wardan, Michael Orford, Lucille Voullaire, Faten Zaibak, Robert Williamson, and Panayiotis A Ioannou*
Cell and Gene Therapy Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia
Cell and Gene Therapy Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
* Corresponding author; email: ioannoup{at}cryptic.rch.unimelb.edu.au.
Reactivation of fetal hemoglobin genes has been proposed as a potential therapeutic procedure in patients with ß-thalassemia, sickle cell disease or other ß-hemoglobinopathies. In vitro model systems based on small plasmid globin gene constructs have previously been used in human and mouse erythroleukemic cell lines to study the molecular mechanisms regulating the expression of the fetal human globin genes and their reactivation by a variety of pharmacological agents. These studies have led to great insights in globin gene regulation and the identification of a number of potential inducers of fetal hemoglobin. In this study we describe the development of enhanced green fluorescence protein (EGFP) reporter systems based on BACs (EBACs) to monitor the activity of the  -, G -, A-,  - and ß-globin genes in the ß-globin locus. Additionally we demonstrate that transfection of erythroleukemia cells with our EBACs is greatly enhanced by expression of EBNA1, which also facilitates episomal maintenance of our constructs in human cells. Our studies in human cells have shown physiologically relevant differences in the expression of each of the globin genes and also demonstrate that hemin is a potent inducer of EGFP expression from EGFP-modified -, G- and A-globin constructs. In contrast the EGFP-modified - and ß-globin constructs consistently produced much lower levels of EGFP expression on hemin induction, mirroring the in vivo ontogeny. The EGFP-modified ß-globin EBAC vector system can thus be used in erythroleukemia cells to evaluate induction of the - and -globin genes from the intact human ß-globin locus.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
N. Bianchi, C. Zuccato, I. Lampronti, M. Borgatti, and R. Gambari
Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of -Thalassemia and Sickle-Cell Anemia
Evid. Based Complement. Altern. Med.,
December 11, 2007;
(2007)
nem139v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Vadolas, M. Nefedov, H. Wardan, S. Mansooriderakshan, L. Voullaire, D. Jamsai, R. Williamson, and P. A. Ioannou
Humanized beta-Thalassemia Mouse Model Containing the Common IVSI-110 Splicing Mutation
J. Biol. Chem.,
March 17, 2006;
281(11):
7399 - 7405.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Vadolas, H. Wardan, M. Orford, R. Williamson, and P. A. Ioannou
Cellular genomic reporter assays for screening and evaluation of inducers of fetal hemoglobin
Hum. Mol. Genet.,
January 15, 2004;
13(2):
223 - 233.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Peters, M. Nefedov, J. Sarsero, J. Pitt, K. J. Fowler, S. Gazeas, S. G. Kahler, and P. A. Ioannou
A Knock-out Mouse Model for Methylmalonic Aciduria Resulting in Neonatal Lethality
J. Biol. Chem.,
December 26, 2003;
278(52):
52909 - 52913.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
